Haemonetics Corp. buy Raymond James
Start price
07.02.25
/
50%
€57.00
Target price
07.02.26
€111.41
Performance (%)
-15.09%
End price
08.02.26
€48.40
Summary
This prediction ended on 08.02.26 with a price of €48.40. The price of Haemonetics Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.09%. Raymond_James has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | - | - | - |
| iShares Core DAX® | -1,10 % | -6,08 % | 0,87 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 18,26 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 26,34 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 13,29 % |
Comments by Raymond_James for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $115.00 price target on the stock, down previously from $120.00.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Current prediction by Raymond_James for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€60.00
09.05.25
09.05.25
€93.63
09.05.26
09.05.26
-14.17%
06.03.26
06.03.26
